BTG3 and Sjogren syndrome: From the 13,849 patients diagnosed based on ICD-9/10 codes with Sjögren's disease in our study, we found that 45.0% tested positive for antinuclear antibodies (ANA), 51.5% positive for Sjögren's syndrome (SS)-related antigen A/Ro (SSA), 37.9% positive for SS-related antigen B/La (SSB), 38% positive for rheumatoid factor (RF), and 15.8% had low dehydroepiandrosterone (DHEA) (Table 3).